Pharmaceutical industry – Page 45

Feature
Reaching out

2014-05-22T00:00:00Z

Andy Extance surveys how pharma uses outsourcing in a variety of different ways
Business
Novartis enhances its focus with eyecare deal

2014-05-21T00:00:00Z

Swiss firm buys rights to wet AMD drug from Ophthotech for up to $1bn
Business
Abbott to buy Chile’s CFR for $3bn

2014-05-21T00:00:00Z

Generics deal reinforces firm’s Latin American presence
Business
AstraZeneca refuses Pfizer’s ‘final’ offer

2014-05-19T00:00:00Z

Pfizer pledges not to make hostile bid direct to shareholders
Business
Lilly protests $450m Brazilian fine

2014-05-15T00:00:00Z

Firm says chemicals employees were allegedly exposed to were never used at site
Business
Chinese police hand GSK bribery case to prosecutors

2014-05-14T00:00:00Z

Investigation alleges senior manager ordered staff to hand out bribes
Business
Pfizer presses hard for AstraZeneca deal

2014-05-14T00:00:00Z

Executives face down international controversy over tax schemes and previous post-merger record
Business
Bayer wins race to buy Merck & Co consumer care

2014-05-09T00:00:00Z

$14bn deal will make Aspirin inventor the number two over-the-counter healthcare company
Business
UK regulator warning over online herbal remedies

2014-05-07T00:00:00Z

Products found to contain toxic metals or undeclared prescription-only drugs
Business
Insider trading allegations stall Sun–Ranbaxy deal

2014-05-07T00:00:00Z

Companies deny wrongdoing in lead-up to merger announcement
Business
Forest Labs buys Furiex for bowel drug

2014-05-02T00:00:00Z

Firm will immediately sell on other assets to Royalty Pharma
Business
Pfizer courts AstraZeneca megamerger

2014-04-29T00:00:00Z

AZ rebuffs public dealmongering
Business
Valeant launches hostile bid for Allergan

2014-04-29T00:00:00Z

Botox maker swallows ‘poison pill’ in defence
Opinion
Engineering serendipity

2014-04-25T00:00:00Z

It takes more than random stumbling to find new reactions, says Derek Lowe
Business
Generics triumph in anti-inflammatory patent battle

2014-04-25T00:00:00Z

Pfizer settles deals to allow copycat celecoxib
Business
$25bn-plus trade sharpens pharma giants’ focus

2014-04-25T00:00:00Z

Novartis’ asset swaps with GSK and Eli Lilly are the latest steps in an ongoing streamlining process
Business
GSK corruption investigation widens

2014-04-23T00:00:00Z

BBC investigation airs allegations of misconduct in Poland
Business
Missing safety risk emails draw $9bn Actos fine

2014-04-11T00:00:00Z

Judge finds absence of Takeda documentation in bladder cancer case ‘disturbing’
Business
Sun set on Ranbaxy rescue

2014-04-09T00:00:00Z

Acquiring beleaguered firm will create India’s biggest pharmaceutical company
Business
GSK investigates bribery claims in the Middle East

2014-04-09T00:00:00Z

Leaked emails claim GlaxoSmithKline bribed Iraqi doctors and healthcare officials